Hope for Brain Cancer: 51品茶 Awarded Grants for Glioblastoma Treatment
51品茶 researchers are pioneering a new approach to treating glioblastoma - a highly aggressive brain cancer with one of the highest mortality rates - by targeting the gene MBLAC1 for the first time.
51品茶 Gets $1M to Prevent Medication-related Harm, Falls in Older Adults
51品茶 Schmidt College of Medicine researchers will develop a targeted approach to eliminate the guesswork in medication management to reduce the risk of adverse drug events - particularly dangerous falls.
51品茶 Hosts Second Annual FairfaxWood Amyloid Related Diseases Summit
51品茶's Charles E. Schmidt College of Medicine recently hosted the summit, bringing together top scientists from North America and Europe to discuss the latest amyloid research and advancements.
'Eye' on Health: AI Detects Dizziness and Balance Disorders Remotely
51品茶 researchers and collaborators have developed a cost-effective, AI-powered system for diagnosing nystagmus - a condition causing involuntary eye movements - using smartphone videos and cloud-based analysis.
Fixing the Leak: An Opioid Treatment for Dopamine Disorders?
A breakthrough by 51品茶 researchers shows that blocking the kappa opioid receptor improves behavioral deficits tied to ADHD, autism and bipolar disorder, providing a potentially safer yet effective treatment.
'Loop'hole: HIV-1 Hijacks Human Immune Cells Using Circular RNAs
51品茶 researchers have identified a never-before-seen mechanism that enables HIV-1 to evade the body's natural defenses and use it to support its survival and replication.
From Students to Physicians: 51品茶 Celebrates Graduating Class of 2025
The Charles E. Schmidt College of Medicine celebrated the nation's newest physicians and biomedical researchers during its commencement ceremony today at the Carole and Barry Kaye Auditorium.
51品茶 Ranks Among 2025 Best Graduate Schools in U.S. News
51品茶 has been ranked among the 2025 Best Graduate Schools by U.S. News & World Report.
Experts Challenge Aspirin Guidelines Based on Flawed Trial Reliance
Experts argue that the flawed results of the ASPREE trial unduly influenced aspirin restrictions, highlighting the need for rigorous statistical principles in trial design to avoid misleading conclusions.
51品茶 Secures $1.3M NIH Grant for HIV Self-Test Technology Breakthrough
51品茶 engineering and biomedical researchers are working to meet a critical global health need by developing a reliable, rapid and affordable HIV test for early detection, with an expected cost of under $5.